Inhibition of p53-activated transcription is an integral part of the mechanism by which early region 1B 55K oncoprotein (E1B-55K) from adenovirus type 5 (Ad5) contributes to complete cell transformation in combination with Ad E1A. In addition, more recent data suggest that the mode of action of the Ad protein during transformation may involve additional functions and other protein interactions. In the present study, we performed a comprehensive mutational analysis to assign further transforming functions of Ad5 E1B-55K to distinct domains within the viral polypeptide. Results from these studies show that the functions required for transformation are encoded within several patches of the 55K primary sequence, including several clustered cysteine and histidine residues, some of which match the consensus for zinc fingers. In addition, two amino-acid substitutions (C454S/C456S) created a 55K mutant protein, which had substantially reduced transforming activity. Interestingly, the same mutations neither affected binding to p53 nor inhibition of p53-mediated transactivation. Therefore, an activity necessary for efficient transformation of primary rat cells can be separated from functions required for inhibition of p53-stimulated transcription. Our data indicate that this activity is linked to the ability of the Ad5 protein to bind to components of the Mre11/Rad50/NBS1 DNA doublestrand break repair complex, and/or its ability to assemble multiprotein aggregates in the cytoplasm and nucleus of transformed rat cells. These results introduce a new function for Ad5 E1B-55K and suggest that the viral protein contributes to cell transformation through p53 transcription-dependent and -independent pathways.
Introduction
Over the past years, it has been generally accepted that the 55K proteins encoded in early regions 1B (E1B-55K) from human adenovirus types 2, 5 and 12 (Ad2/5/12) contribute to complete cell transformation by antagonizing programmed cell death (apoptosis) and growth arrest, which primarily result from the induction and metabolic stabilization of the tumor suppressor protein p53 by Ad E1A (for review, see Endter and Dobner, 2004) . In the case of Ad2/5 E1B-55K products, these growth-promoting activities correlate with their ability to act as direct transcriptional repressors that are targeted to p53-responsive promoters by binding to p53 (for review, see Berk, 2005) . This silencing activity also involves interactions with cellular proteins implicated in transcriptional control, phosphorylation (Teodoro and Branton, 1997) and SUMOylation, which regulates efficient nuclear import and/or intranuclear targeting of Ad5 E1B-55K (Endter et al., 2001) . Consistent with this, nuclear accumulation of Ad5 E1B-55K by functional inactivation of its leucine-rich nuclear export signal (NES) augments transformation of primary rat cells (Endter et al., 2005) . This 'gain of function' correlates with enhanced inhibition of p53-stimulated transcription and the accumulation of p53 and the promyelocytic leukemia protein (PML) in large subnuclear aggregates (Endter et al., 2005) . The latter observation indicates that transcriptional inhibition of p53 by Ad E1B-55K may involve interactions with PML-containing nuclear bodies (PML-NBs) (Endter et al., 2001 ) and PML-NBassociated proteins such as Daxx Wan et al., 2004) .
In addition to their accepted role as potent repressors of p53-activated genes, it is now becoming clear that the mode of action of Ad E1B-55K products during transformation involves additional functions and other protein interactions (Gabler et al., 1998; Liao et al., 1999; Koch et al., 2001; Barral et al., 2005) . Collectively available data suggest that these activities are linked in part to p53 transcription-independent pathways (Lo¨ber et al., 2002; Hobom and Dobbelstein, 2004; Sieber and Dobner, 2007) , and to the ability of Ad2/5 E1B-55K products to inactivate p53 and the tumor suppressor protein WT1 by sequestration into a cytoplasmic inclusion body (Maheswaran et al., 1998; Grand et al., 1999; Hutton et al., 2000; typically situated around the microtubule organizing center (MTOC) (Brown et al., 1994) . The cytoplasmic restriction imposed upon p53 requires binding of Ad2/5 E1B-55K to p53, but is independent of CRM1-mediated nuclear export of the viral protein in transformed rat cells (Endter et al., 2005) . A similar situation has been described for Ad12 E1B-55K, which forms p53-containing cytoplasmic inclusions after translation, but, before import into the nucleus . Recent work has shown that E1B-55K in Ad5-transformed human 293 cells also binds to and recruits components of the Mre11/Rad50/NBS1 DNA complex (MRN) into cytoplasmic inclusion bodies by a mechanism that is dependent on CRM1-mediated nuclear export and requires active transport on microtubules on retrograde motors to the MTOC (Liu et al., 2005) . The latter observation suggests that cytoplasmic inclusion bodies formed by Ad2/5 E1B-55K fit the criteria for aggresomes, a single, mostly spherical subcellular structure, implicated in the removal of misfolded and aggregated proteins from the cytosol by proteasomal and/or lysosomal degradation (for reviews, see Kopito, 2000; Garcia-Mata et al., 2002) .
In this report, we provide further support for the model that an activity of E1B-55K necessary for efficient transformation of primary rat cells can be separated from functions required for inhibition of p53 transactivation (Sieber and Dobner, 2007) . Our data suggest that this activity is linked to the intrinsic ability of wild-type (wt) E1B-55K to form a single cytoplasmic body and/or multiprotein complexes in the nucleus by a mechanism that may involve interaction with Mre11 and other MRN subunits.
Results
Several conserved cysteine and histidine residues in Ad5 E1B-55K contribute to efficient transformation of primary rat epithelial cells in cooperation with Ad5 E1A To identify further regions in the Ad5 E1B-55K oncoprotein required for transformation of primary mammalian cells, we generated a panel of mutants containing single-or double-amino-acid substitutions in different segments of the 55K polypeptide, including a predicted elongin B-and C-binding domain (Blanchette et al., 2004) , a proposed zinc-finger motif (Flint and Gonzalez, 2003) and several other clustered histidine and cysteine residues, some of which are conserved in E1B-55K proteins from human subgroup A to F adenoviruses (Figure 1 ). These were tested for their ability to (i) inhibit p53-stimulated transcription in plasmid-transfected H1299 cells, (ii) transform primary baby rat kidney (BRK) cells in cooperation with Ad E1A, (iii) produce stable 55K proteins in transformed BRK lines and (iv) form a single E1B/p53-positive cytoplasmic perinuclear body, a characteristic of all subgroup C Ad2/5-transformed mammalian cells ( Figure 2 ). As control, we included the previously described Ad5 E1B-55K mutant pm490/1/5A (Figure 1 ). This mutant protein interacts with p53, but is defective in blocking p53-dependent and -independent transcription as well as cell transformation (Teodoro and Branton, 1997) .
On the basis of these analyses, the tested mutants were grouped into four classes (I-IV). Mutants in class I (C184T and C393S/H396L) behaved like wt 55K in all of the assays (Table 2 in Supplementary data; Figures 2d-f). Mutants in class II (L180P/C184F, L180A/C184S and H373L/H377L) were significantly impaired in repression of p53-stimulated transcription as well as focal transformation compared with the wt protein. In Figure 1 Domains and motifs in the Ad5 E1B-55K protein. The amino-acid sequences of the leucine-rich NES, the SUMO1-conjugation motif (S), the putative elongin B-and C-binding domain (BC), and the predicted zinc finger (C2H3) are indicated above. Conserved amino-acid residues are underlined and numbers denote the position of the first amino acid within each motif. The location of cysteine and histidine residues in the Ad5 E1B-55K polypeptide are shown by short and long vertical lines, respectively. Black dots on top of the vertical lines indicate cysteine and histidine residues conserved in large E1B proteins from human subgroup A to F adenoviruses. The positions of the amino-acid changes within the tested E1B-55K mutants are shown below in black triangles. In most cases the introduced mutation consists of the substitution of a serine residue for cysteine or a leucine residue for histidine. In E1B-C184T the cysteine at position 184 was replaced by a threonine conserved in the predicted BC-box of the large E1B proteins from Ad40/41. Mutant pm490/1/5A carries three alanine substitutions, which abolish phosphorylation of highly conserved serine (S490 and S491) and threonine (T495) residues at the C terminus of Ad5 E1B-55K (Teodoro et al., 1994) . The regions in Ad2/5 E1B-55K, reported to mediate binding to p53, repression of p53-stimulated transcription, repression of p53-independent transcription and focus formation in cooperation with Ad E1A, are shown on the bottom of the figure in gray bars and were assembled from several publications cited in the text. Ad5, adenovirus 5; E1B 55K, early region 1B 55K oncoprotein; NES, nuclear export signal.
Cell transformation by Ad5 E1B-55K B Härtl et al nearly all of these cells (90%) the mutant proteins were found evenly distributed throughout the cytoplasm, whereas p53 exhibited a diffuse nuclear staining (Figures 2g-i ). Only 10% of the cells examined (n>100) contained a single E1B-55K/p53-positive cytoplasmic condensation (Figures 2j-l) , which, on average, was considerably smaller than the perinuclear body in transformed BRK cells expressing the wt or class I mutant proteins (Figures 2a-f ). Mutants in class III (H344L/C348S and S490A/S491A/T495A) were severely defective in the repression of p53-stimulated transcription and focal transformation. Moreover, none of the few foci generated by transfection of plasmids producing the H344L/C348S and S490A/S491A/T495A mutant proteins could be established into permanent cell lines. Finally, mutants in class IV (C283S/C288S, C361S and C454S/C456S) exhibited a 5-to 10-fold reduction in focus-forming activity, although all of them inhibited p53-transactivation of the luciferase reporter plasmid comparable to wt 55K (Table 2 in Supplementary data). Similar to E1B mutants in class II, mutants C283S/ C288S or C361S accumulated to extremely reduced (C283S/C288S) or non-detectable (C361S) levels in the established cell lines. A notable exception was mutant C454S/C456S, which accumulated to nearly wt levels, and, interestingly, was found in numerous, irregularly shaped cytoplasmic bodies, some of which also contained p53 (Figures 2m-o) .
The E1B-C454S/456S mutant blocks p53-dependent and -independent transcription To substantiate the results from the transient reporter assays, the E1B-C454S/C456S mutant was further tested together with class I mutant E1B-C184T and class II mutant E1B-L180P/C184F for its ability to inhibit p53-dependent transcription using a luciferase reporter containing the cellular p53-responsive Cyclin G promoter ( Figure 3a ). In parallel, we evaluated whether the mutations interfere with the intrinsic repression activity of the Ad5 E1B protein (Figure 3b ). Consistent with the results described before (Table 2 in Supplementary data) E1B mutants C184T and C454S/C456S blocked p53 induction of the Cyclin G promoter nearly as efficiently as the wt protein, whereas co-transfection of pE1B-L180A/C184S resulted in an only 20-40% reduction of luciferase activity (Figure 3a) . The observed increase in promoter activity is likely due to the reduced expression levels of the E1B-L180A/C184S mutant ( Figure 3b , lane 3), indicating that amino-acid changes in the elongin B-and C-binding domain motif (C184T and L180A/C184S) differentially affect the stability of the Ad protein in transiently transfected and stably transformed cells ( Figure 3a ; Blanchette et al., 2004) . Co-transfection of plasmids encoding wt E1B-55K and the mutants fused to the Gal4 DNA-binding domain efficiently repressed transcription of the reporter plasmid pGal4TK-Luc (Figure 3c ). Thus, none of the aminoacid changes impair the ability of E1B-55K to function as a direct transcriptional repressor when tethered to the Herpes simplex virus thymidine kinase promoter in pGal4TK-Luc. Finally, to confirm that E1B-C454S/ C456S can block p53-stimulated transcription in transformed BRK cells, we tested p53-dependent activation of the p21 WAF1/Cip1 gene by quantitative real-time PCR after g-irradiation of AB120 and AB72 cells stably expressing the wt and mutant protein, respectively ( Figure 3e ). As controls, stabilization of p53 was monitored by immunoblotting ( Figure 3f ) and induction of DNA double-strand breaks was visualized with antig-H2AX antibody by indirect immunofluorescence (Figure 3g) . Results from these assays show that production of p21 mRNA is induced in the BRK control cells, whereas p21 mRNA levels are reduced at 6 and 12 h after g-irradiation in both wt and mutant expressing cells.
These results together with the findings described above suggest that E1B-C454S/C456S is functional and indicate that C454S/C456S substitutions interfere with an activity of the viral protein that promotes cell transformation by a mechanism that is independent from inhibition of p53-stimulated transcription. were double labeled in situ with anti-E1B-55K mouse monoclonal antibody (mAb) 2A6 (a-E1B) and the rabbit polyclonal serum FL393 specific for p53 (a-p53). These were detected with fluorescein isothiocyanate-and Texas Red-conjugated secondary antibodies, respectively. Anti-E1B (red; a, d, g, j and m) and antip53 (green; b, e, h, k and n) staining patterns are shown. An overlay of these two patterns (merge) is shown in c, f, i, l and o. Arrowheads indicate the small E1B/p53-positive perinuclear body, present in a portion (approximately 10%) of transformed BRK cells expressing class II E1B mutant proteins. In all panels nuclei are shown by dotted lines. Magnification, Â 7600. BRK, baby rat kidney; E1B-55K, early region 1B 55K oncoprotein; wt, wild type.
Cell transformation by Ad5 E1B-55K B Härtl et al Furthermore, they suggest that this activity is linked to the intrinsic ability of the Ad5 protein to form a single, usually spherical, cytoplasmic inclusion body, typically present in subgroup C Ad2/5-transformed mammalian cells.
Cysteine residues 454 and 456 are essential to form the E1B-55K cytoplasmic inclusion body Recent work has shown that Ad2/5 E1B-55K cytoplasmic inclusion bodies fit the criteria for aggresomes ( WAF1/Cip1 after 16 Gy g-irradiation of AB120 and AB72 cells. The p21 mRNA levels were determined by quantitative real-time PCR at 6 and 12 h after irradiation, and standardized for glyceraldehyde 3-phosphate dehydrogenase mRNA. The mRNA levels in the non-irradiated cells were arbitrarily set to 1. The mean and standard deviation are presented for two independent experiments, each performed in triplicates. (f) Steady-state concentration of p53 after 16 Gy g-irradiation of BRK (lanes 1-3), AB120 (lanes 4-6) and AB72 cells (lanes 7-9). p53 and b-actin were detected by immunoblotting of total-cell lysates at 6 and 12 h after irradiation using mAb FL393 (p53) and . (g) g-H2AX focus formation. AB120 and AB72 cells were stained 8 h after 10 Gy g-irradiation (b and d) with anti-g-H2AX mouse mAb. Panels (a) and (c) show the control staining of nonirradiated cells. In all panels, nuclei are shown by dotted lines. Magnification, Â 7600. BRK, baby rat kidney; E1B-55K, early region 1B 55K oncoprotein; mAb, monoclonal antibody; wt, wild type. (Liu et al., 2005) , another characteristic of some aggresomes (Kopito, 2000) . These findings together with the atypical cytoplasmic staining pattern of the E1B-C454S/C456S mutant raised the possibility that both amino-acid changes interfere with aggresome formation in transformed BRK cells. We, therefore, compared the subcellular distribution of wt E1B-55K and mutant E1B-C454S/C456S with vimentin and the centrosomal marker protein g-tubulin in primary BRK, AB120 and AB72 cells by double-label immunofluorescence (Figure 4) . In primary BRK cells, vimentin was seen in an array of long fibrous elements ( Figure 4A , a-c), while at the resolution afforded by conventional immunofluorescence, g-tubulin was found mostly concentrated in one or two closely situated dots ( Figure 4B , a-c), consistent with the description of centrosomes in inter-or S-phase cells (for review, see Fukasawa, 2005) . A comparable pattern of staining for the centrosome marker was observed in AB120 cells ( Figure 4B, d-f ). Typically, in these cells the centrosome was surrounded by the E1B-55K cytoplasmic inclusion body, demonstrating that this structure in stably transformed rat cells is formed around the MTOC. Interestingly, however, none of the cells examined (n>100) exhibited a rearrangement of the vimentin cytoskeleton ( Figure 4A, d-f) . Also, it appears that formation of the cytoplasmic inclusion is not accompanied by the formation of a vimentin 'cage' (Johnston et al., 1998) , as this characteristic structure was not observed when AB120 cells were analysed by double-label immunofluorescence and confocal laser scanning microscopy (data not shown). These results suggest that E1B-55K cytoplasmic inclusion bodies in transformed rat cells may correspond to aggresomes, which do not trigger vimentin reorganization and formation of a vimentin 'cage' (Garcia-Mata et al., 2002; Lee et al., 2002) . In sharp contrast, the vimentin cytoskeleton was completely collapsed in AB72 cells and the intermediate filament protein was almost entirely redistributed to the multiple E1B-C454S/C456S perinuclear aggregates ( Figure 4A, g-i) . In addition, nearly all of the cells showed a correlation between E1B-55K fluorescence and staining for g-tubulin ( Figure 4B, g-i) . These results demonstrate that two cysteine residues at amino-acid positions 454 and 456 are essential to form and/or maintain a single E1B-55K cytoplasmic inclusion body at the MTOC in transformed rat cells. Consequently, accurate formation of this structure appears to be critical to initiate and/or maintain complete cell transformation in combination with Ad E1A.
The E1B-C454S/C456 mutant fails to sequester Mre11 into the cytoplasmic inclusion body Given these findings, we next tested by double-label immunofluorescence whether the C454S/C456S
substitutions interfere with the E1B-dependent deposition of the MRN subunits Mre11 and Rad50 into cytoplasmic inclusion bodies ( Figure 5 ). As predicted, most of the wt E1B-55K present in AB120 cells was concentrated together with a large portion of Mre11 and Rad50 in a single perinuclear body ( Figures 5A and B d-f ).
In addition, Mre11 exhibited a diffuse and punctate nuclear staining, whereas Rad50 was seen distributed diffusely throughout the nucleoplasm. These data confirm that Mre11 and Rad50 are recruited to cytoplasmic E1B-55K inclusion bodies in transformed rat cells. A different pattern of localization for both cellular proteins was observed in AB72 cells (Figures 5A Cell transformation by Ad5 E1B-55K B Härtl et al and B). In all of the cells examined (n>100) Mre11 was evenly distributed throughout the entire cytoplasm ( Figure 5A , g-i), whereas a large portion of Rad50 accumulated around the nuclear membrane in a perinuclear manner, partially coinciding with the E1B-C454S/C456S cytoplasmic aggregates ( Figure 5B, g-i) . These data demonstrate that the E1B-C454S/C456S mutant fails to sequester Mre11 and a large fraction of Rad50, but not p53, into aberrant cytoplasmic inclusion bodies. A possible explanation for this result could be that substitutions at positions 454 and 456 differentially affect the interaction with p53, Mre11 and Rad50.
The C454S/C456S substitutions eliminate binding of Ad5 E1B-55K to Mre11 To test this model, protein interactions were assayed by combined immunoprecipitation/immunoblotting from total-cell extracts of AB120, AB72 and AB115 cells (Figure 6a ), the latter expressing the E1B-NES mutant protein, previously reported to sequester p53 into a single, typically elongated E1B-positive cytoplasmic body (Endter et al., 2005) . As predicted E1B-C454S/ C456S and E1B-NES co-precipitated p53 comparable to wt E1B-55K (Figure 6b, lanes 6-8) , while binding to Mre11 was evident only with the wt protein and the NES mutant (Figure 6b, lanes 6 and 8) . Also, considerably less Rad50 co-precipitated with the E1B-C454S/C456S mutant (Figure 6b, lane 7) , consistent with the data obtained in the immunofluorescence studies. Thus, the same mutations that abolish formation of a single cytoplasmic inclusion body and cytoplasmic sequestration of Mre11 also eliminate the interaction with the MRN subunit. These results are surprising in light of previous reports, that a fourresidue insertion at amino-acid position 354, situated within the putative zinc finger of the Ad2 E1B protein (E1B-H354) (Yew et al., 1990) , eliminates the interaction of the Ad2 protein with and cytoplasmic sequestration of Mre11 (Carson et al., 2003; Liu et al., 2005) .
Thus, it appears that two separate regions in the primary sequence of Ad2/5 E1B-55K mediate the interaction with Mre11.
To substantiate the results from the in vivo binding assays, wt 55K and the E1B mutants were additionally tested for their ability to degrade Mre11 and p53 in combination with Ad5 E4orf6 in plasmid-transfected p53-negative H1299 cells. A representative result from several degradation assays is shown in Figure 6c . In agreement with the results described before, the E1B-NES mutant protein degraded endogenous Mre11 comparable to wt 55K (Figure 6c , compare lane 6 with 4), whereas transfection of pE1B-C454S/C456S reproducibly had no or only minor effects on Mre11 steadystate concentrations (Figure 6c, lane 5) . Significantly, the same amino-acid changes did not interfere with the complete degradation of ectopically expressed p53 (Figure 6c , lanes 5 and 6), excluding the possibility that these mutations eliminate the E4orf6-dependent assembly of a high-molecular-weight E3 ubiquitin ligase complex necessary for the polyubiquitination of p53 and presumably Mre11 (Blanchette et al., 2004) . Taken together, these data strongly suggest that amino acids C454 and C456 participate in the binding to Mre11 and demonstrate that active nuclear export of E1B-55K by its NES is not required for efficient degradation of p53 and Mre11 in human H1299 cells.
The cytoplasmic restriction imposed upon Mre11 requires active transport of Ad5 E1B-55K by the CRM1-dependent nuclear export pathway Recent work has demonstrated that sequestration of MRN complexes into E1B-55K aggresomes in human cells inhibits the function of MRN and involves 
i). (B)
Steady-state localization of Rad50, wt E1B-55K and E1B-C454S/ C456S in primary BRK (a-c), AB120 (d-f) and AB72 (g-i) cells. Cells were double-labeled in situ with polyclonal antibody pNB 100-154 specific for Rad50 (a-Rad50, green) and anti-E1B-55K rat mAb 7C11 (a-E1B, red). An overlay of these two patterns (merge) is shown in (c), (f) and (i). In all panels nuclei are shown by dotted lines. Magnification, Â 7600. BRK, baby rat kidney; mAb, monoclonal antibody; E1B-55K, early region 1B 55K oncoprotein; wt, wild type.
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B Härtl et al NES-mediated nuclear export (Liu et al., 2005) . To test this hypothesis in the context of transformed rat cells, we determined the effect of the CRM1 inhibitor, LMB, on the intracellular distribution of p53 and Mre11 in the transformed BRK cell lines by double-label immunofluorescence ( Figure 7) . Consistent with our previously published work (Endter et al., 2005) , AB120 cells grown in the presence of LMB exhibited an E1B/p53-positive cytoplasmic inclusion body ( Figure 7A, a-c) , while none of these E1B-positive structures contained Mre11 ( Figure 7A , d-f). Thus, cytoplasmic deposition of Mre11 in transformed rat cells is dependent on active CRM1-mediated nuclear export of E1B-55K. Also, as predicted (Endter et al., 2005) , treatment of AB120 cells with LMB induced the formation of nuclear aggregates containing E1B-55K, p53 ( Figure 7A , a-c), Mre11 ( Figure 7A, d-f ) and PML (Figure 8, panels d-f in Supplementary data) . Surprisingly, however, no E1B-positive subnuclear foci were evident in LMB-treated AB72 cells expressing the E1B-C454S/C456S mutant ( Figure 7A, g-l; and Figure  8 , panels j-l in Supplementary data). Rather, by focusing through the depth of the nucleus it appeared that Mre11 and a fraction of p53 and the mutant E1B protein were uniformly distributed throughout the nucleoplasm, while PML exhibited its characteristic dot-like staining (Figure 8 , panels k and l in Supplementary data).
Further evidence that cytoplasmic deposition of Mre11 is dependent on active nuclear export of E1B-55K came from experiments where we examined the localization of p53, Mre11 and E1B-55K in E1B-NESexpressing AB115 cells by double-label immunofluorescence ( Figure 7B ). As described earlier (Endter et al., 2005) , the E1B-NES mutant was seen evenly distributed throughout the nucleoplasm and a large portion of this protein colocalized with p53 ( Figure 7B , a-c) and also Mre11 ( Figure 7B , d-f) in several brightly stained nuclear foci, which, however, were larger in size than in LMB-treated AB120 cells (compare Figure 7A, a-f ). In addition, nearly all AB115 cells (>90%) contained a single, typically elongated E1B/p53-positive cytoplasmic aggregate ( Figure 7B, a-c) . Importantly, none of the E1B-NES-containing aggregates were stained positive for Mre11 ( Figure 7B, d-f ). These data demonstrate that inactivation of the E1B-NES interferes with the nuclear depletion of Mre11. Furthermore, they indicate that the NES mutations affect the morphology and perinuclear location of the cytoplasmic inclusion, and prevent the characteristic distortion of the nuclear envelope that typically accompanies the formation of the cytoplasmic body at the MTOC. In fact, double labeling of E1B-55K and g-tubulin in AB115 cells demonstrated that in nearly all of the cells examined (n>100) the cytoplasmic body was found dissociated from the centrosome ( Figure 7C, a-c) . This suggests that E1B-NES-containing cytoplasmic bodies are either not assembled at MTOC, or are displaced from the MTOC.
On the basis of these data, we conclude that cytoplasmic deposition of Mre11 is dependent on CRM1-mediated nuclear export of E1B-55K in transformed BRK cells. Furthermore, they demonstrate that blocking nuclear depletion of Mre11 by LMB or functional inactivation of the Ad5 E1B-NES does not interfere with cytoplasmic body formation. These findings, together with the demonstration that the Mre11-deficient binding mutant Ad2 E1B-H354 retains the ability to form a single spherical cytoplasmic inclusion body (Liu et al., 2005) , indicate that binding to and cytoplasmic sequestration of Mre11 is not required to form the characteristic perinuclear inclusion Figure 6 The E1B-C454S/C456S mutant fails to bind to Mre11. (a) Steady-state concentrations of p53, Mre11, Rad50, wt E1B-55K and 55 kDa mutant proteins in primary BRK and transformed BRK cells. Cellular and viral proteins, indicated by black arrowheads, were detected by immunoblotting of total-cell lysates using mAbs M73 (E1A), 2A6 (E1B-55K), FL393 (p53), pNB 100-142 (Mre11) and b-actin (AC-15). (b) Co-immunoprecipitation of p53, Mre11 and Rad50 with E1B-55K. Cellular proteins bound to the 55K proteins were co-precipitated (Ip) with mAb 2A6 (a-E1B), resolved on 10% SDS-PAGE and visualized by immunoblotting using the appropriate primary antibodies. (c) Effect of mutations in E1B-55K on degradation of p53 and Mre11 in plasmid-transfected cells. H1299 cells were transfected with different combinations of plasmids encoding wt E1B-55K, wt E4orf6 or mutant E1B-55K proteins (as described in Materials and methods). Total-cell lysates were prepared and samples were examined by a 10% SDS-PAGE followed by immunoblotting with antibodies pNB-100-1422 (Mre11), DO-1 (p53), 2A6 (E1B-55K), 1807 (E4orf6), AC-15 (b-actin) and Sc-8334 (EGFP). BRK, baby rat kidney; E1B-55K, early region 1B 55K oncoprotein; mAbs, monoclonal antibodies; SDS-PAGE, SDS-polyacrylamide gel electrophoresis; wt, wild type.
Cell transformation by Ad5 E1B-55K B Härtl et al body in transformed BRK cells. Finally, the observation that accumulation of E1B-55K around at the centrosome is dependent on its NES suggests that this localization requires CRM1.
Discussion
Over the past 20 years it has been well documented that large E1B proteins from Ad2/5, and to a lesser extent from Ad12, are capable of forming large cytoplasmic and nuclear protein aggregates in transiently transfected and stably transformed mammalian cells (for review, see Endter and Dobner, 2004) . In the case of Ad2/5 E1B-55K, formation of cytoplasmic aggregates typically occurs around the MTOC (Brown et al., 1994; Johnston et al., 1998; Liu et al., 2005) and is accompanied by the sequestration of a variety of E1B-55K-associated proteins such as p53, WT1 and components of the MRN complex (Maheswaran et al., 1998; Liu et al., 2005) . This cytoplasmic restriction imposed upon p53 and MRN contributes to inhibition of p53-induced growth arrest and apoptosis (Hutton et al., 2000; and blocks MRN function (Liu et al., 2005) . Studies in this report confirm that the cytoplasmic inclusion body in transformed BRK cells expressing wt Ad5 E1B-55K contains Mre11 and Rad50 (Figure 5) , is localized at the MTOC ( Figure 4B ) and may correspond to an aggresome, which, as opposed to human cells, does not trigger vimentin reorganization ( Figure 4A ). It appears that the Ad5 E1B-55K cytoplasmic inclusion body is displaced from the centrosomal region in the absence of a functional E1B-NES ( Figure 7C ) or in the presence of LMB (data not shown). This observation indicates that localization of the cytoplasmic inclusion body at the MTOC requires an active E1B-NES and CRM1, and suggests that this structure can be assembled independent of interactions with components that determine the transport to the MTOC. In support of this, formation of cytoplasmic aggregates by Ad12 E1B-55K, which lacks an NES (Kra¨tzer et al., 2000) , does not occur around the MTOC . The involvement of CRM1 in the localization of Ad5 E1B-55K and the cytoplasmic inclusion body to the MTOC is intriguing because the CRM1/Ran complex has been recently implicated in the regulation of centrosome duplication during cell-cycle progression (Budhu and Wang, 2005) . Most interestingly, disruption of these processes may lead to genomic instability and an acceleration of oncogenesis (for review, see Fukasawa, 2005) , just as we have reported for the Ad5 E1B-NES mutant (Endter et al., 2005) . Double-label immunofluorescence was used to visualize g-tubulin (a-g-tubulin, green) and E1B-55K (a-E1B, red) in AB115 cells. Merge indicates the overlay of these images. Open and filled arrowheads in (c) indicate the centrosome and the cytoplasmic inclusion body, respectively. The inset in (c) is a five-fold enlargement illustrating the localization of the centrosome and the E1B-55K cytoplasmic inclusion. In all panels nuclei are shown by dotted lines. Magnification, Â 7600. BRK, baby rat kidney; E1B-55K, early region 1B 55K oncoprotein; mAbs, monoclonal antibodies; NES, nuclear export signal; wt, wild type.
Adenovirus E1B-55K products also form aggregates in the nucleus, in particular under conditions that inactivate nucleocytoplasmic transport of Ad2/5 E1B-55K by the CRM1-mediated export pathway (Kra¨tzer et al., 2000; Endter et al., 2001 Endter et al., , 2005 Carter et al., 2003; Flint et al., 2005) . Similar to cytoplasmic inclusion bodies, formation of the spherical nuclear aggregates is accompanied by the relocalization of p53, PML (Endter et al., 2005) and Mre11 ( Figures 7A and B) . Sequestration of these cellular factors into E1B-55K nuclear aggregates enhances the inhibition of p53-stimulated transcription and focal as well as oncogenic transformation of primary BRK cells (Endter et al., 2005) , suggesting that Ad5 E1B-55K may inactivate p53 and MRN functions in the context of PML-NBs. Given these observations, along with the findings described above, we find it intriguing that two amino substitutions that abolish the formation of cytoplasmic and nuclear aggregates substantially reduce the transforming activity of Ad5 E1B-55K.
As yet, we can only speculate about how substitutions C454S/C456S impair Ad5 E1B-55K transforming function. The observation that sequestration of p53 into a cytoplasmic inclusion body blocks the import of p53 into mitochondria suggests that substitutions C454S/C456S may interfere with the ability of the Ad5 protein to antagonize proapoptotic activities of p53, operating within the mitochondrial pathway of apoptosis. Considerable evidence suggests that this antiproliferative activity of p53 is largely mediated through transcription-independent functions (for review, see Moll et al., 2005) . Such a mechanism would fit well with our result that E1B-C454S/C456S is defective in focal transformation, but blocks p53-stimulated transcription (Table 2 in Supplementary data; Figure 3) , and the finding that none of the few foci induced by pm490/1/5A could be established into permanent cell lines (Table 2 in Supplementary data), because this mutant is defective in both inhibition of p53-stimulated transcription (Teodoro et al., 1994; Teodoro and Branton, 1997, and Table 2 in Supplementary data) and formation of the cytoplasmic inclusion body . Alternatively, and/or additionally, the result that E1B-C454S/C456S induces a complete reorganization of the vimentin cytoskeleton (Figure 4 ) raises the possibility that aberrant accumulation of E1B-C454S/C456S in the cytoplasm potentially interferes with regulatory cytosolic pathways. This predicts that accurate formation of a single cytoplasmic inclusion body rather than cytoplasmic sequestration of p53 and MRN, is critical for the initiation of transformation and/or maintenance of the transformed cell phenotype. In support of this, amino-acid substitution, mutations in the E1B-NES retain the ability of the mutant protein to form a single E1B/p53 cytoplasmic inclusion body (Endter et al., 2005;  Figure 7) , and do not affect the integrity of the vimentin cytoskeleton in AB115 cells (data not shown). Finally, we suggest that the loss of binding to Mre11 interferes with the inhibition of MRN function and thus may be detrimental to Ad5 E1B-55K transforming function (discussed below). It should be noted, however, that the Mre11 binding-deficient mutant Ad2 E1B-H354 (Yew et al., 1990; Carson et al., 2003) is not defective for transformation of primary BRK cells (Yew and Berk, 1992) . This difference in transforming activity of the E1B-55K mutant is unclear. Possibly, the defect of the Ad2 E1B-H354 mutant is compensated by the transforming activity of the E1B-156R product (Sieber and Dobner, 2007) , which is generated by alternative splicing from the major 2.28-kb E1B 22S mRNA (Anderson et al., 1984) , and contains the 79 N-terminal and 77 C-terminal amino acids of E1B-55K, including C454 and C456.
A number of provisional proposals can be made at this point concerning the mechanism by which aminoacid substitution mutations C454S/C456S eliminate formation of cytoplasmic and nuclear aggregates. The demonstration that C454S/C456S interferes with both processes strongly suggests that they are related and are regulated through the same activity. Also, the fact that inhibition of Mre11 nuclear export either by LMB ( Figure 7A ) or functional inactivation of the E1B-NES ( Figure 7B ) does not affect the formation of a single cytoplasmic inclusion body suggests that this process is independent of interactions with Mre11. Whether a similar situation applies to the formation of nuclear aggregates remains to be seen. Nonetheless, these data indicate that C454/C456 regulate at least two apparently separate functions of the Ad5 protein: binding to Mre11 and formation of a single, mostly spherical cytoplasmic inclusion body. This, along with the finding that two regions in the linear sequence of Ad2/5 E1B-55K participate in the binding to MRN, further implies that amino acids at position 354 and C454/C456 may indirectly participate in this protein interaction. Although clearly speculative at this point, assuming that formation of nuclear and cytoplasmic aggregates are related, we currently favor the model that both cysteine residues regulate the intrinsic ability of the Ad5 protein to form spherical aggregates in both cell compartments. This activity may involve interactions with cellular factors that regulate phosphorylation of Ad5 E1B-55K at S490/S491/T495, and/or interactions with chaperones invariably associated with aggresomes (for review, see Garcia-Mata et al., 2002) and transiently with PML-NBs (Florin et al., 2004) . Both possibilities are intriguing because the equivalent residues in Ad12 E1B-55K (S476/S477) are required for the cytoplasmic body formation and because Ad5 E1B-55K binds to heat-shock protein 70 (Liu et al., 2005) . In fact, reversible phosphorylation and/or binding to heat-shock protein 70 could induce conformational changes in the Ad5 protein that differentially regulate binding to Mre11 and aggregate formation. As an alternative, it is reasonable to believe that formation of nuclear aggregates by C454/C456 is linked to interactions with PML-associated factors. Because MRN complexes transiently associate with PML-NBs, usually in response to DNA damage or cellular stress (for review, see Dellaire and Bazett-Jones, 2004 ), Mre11 is a prime candidate for this interaction. For example, such an activity could account for the observation that Ad12 E1B-55K extends the life span of normal mammalian cells in culture by several fold, most likely by maintaining or protecting telomeres (Gallimore et al., 1997) . Whether this 'anti-senescence' property of Ad12 E1B-55K is related to PML-NBs and/or MRN complexes, is unknown. Nevertheless, inactivation of the functions of MRN by Ad E1B-55K in the context of PML-NBs would antagonize cell-cycle arrest, senescence and apoptosis, typically activated by DNA damage response pathways by shortened chromosomal ends and thus could be critical to escape crises; an obligatory step in the immortalization and complete transformation of primary mammalian cells (for review, see Greenberg, 2005) . Further studies are now under way to test these possibilities.
Materials and methods

Plasmids and mutagenesis
Mutant Ad5 E1B-55K plasmids ( Figure 1 ; Table 2 in Supplementary data) were generated from wt pE1B-55K (Endter et al., 2001 ) and pGal4E1B-55K (Dobner et al., 1996) by using the QuikChange Site-Directed Mutagenesis Kit (Stratagene Europe, Amsterdam, Netherlands), with complementary oligonucleotide pairs (Table 1 in Supplementary data). Plasmids pE1A (Endter et al., 2001) , pC53-SN3 (Dobner et al., 1996) , pEGFP (Clontech-Takara Europe, Saint-Germain-en-Laye, France) and the RGC-firefly luciferase reporter plasmids pGalTK-Luc (Nevels et al., 1997) , pRELuc (Endter et al., 2001 ) and pCyclinG-Luc (Okamoto and Beach, 1994) have been described previously.
Transformation assays, cell lines and transient transfections
The preparation of primary BRK cells and BRK transformation assays were performed exactly as described recently (Nevels and Dobner, 2007) . AB120 cells express wt E1B-55K (Endter et al., 2001) . AB115 cells produce the E1B-55K NES mutant protein (Endter et al., 2005) and AB72 cells were derived from transfection of primary BRK cells with pE1A and pE1B-C454S/C456S. Primary BRK cells and the p53-negative human cell line H1299 (Mitsudomi et al., 1992) were grown in Dulbecco's modified Eagle's medium supplemented with 5% fetal calf serum, 100 U of penicillin and 100 mg of streptomycin per milliliter. For all other cell lines the same medium plus 500 mg of G418 (Calbiochem, San Diego, CA, USA) per milliliter was used.
For dual luciferase assays, subconfluent H1299 cells were transfected as described previously (Endter et al., 2005) . Totalcell extracts were prepared 48 h after transfection in lysis buffer, and RGC-firefly luciferase activity was assayed with 10 ml of extract in an automated luminometer (Lumat LB9510; Berthold Technologies, Bad Wildbad, Germany). All samples were normalized for transfection efficiency by measuring Renilla-luciferase activity.
For the degradation assay, 2 Â 10 5 H1299 cells were transfected with the liposome reagent lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA). The transfection mixtures contained 0.125 mg of pEGFP, 0.25 mg of p53, 0.25-1.0 mg of E1B-55K wt or mutant plasmids and 0.5 mg of pCMV-E4orf6. Cells were harvested at 24 h after transfection and lysed in NP40 lysis buffer (50 mM Tris pH 8, 150 mM NaCl, 5 mM EDTA, 1% NP40, 0.1% SDS, 0.1% Triton X-100 and 1 mM DTT) containing inhibitors (4 mM NaF, 2 mM NaPP, 500 mM sodium vanadate, 200 mg ml À1 phenylmethylsulfonyl fluoride, 2 mg ml À1 aprotinin and 5 mg ml À1 leupeptin). Equal amounts of total-cell extract were then subjected to immunoblotting as described below.
Quantitative real-time PCR Subconfluent AB120 and AB72 cells were g-irradiated (10 or 16 Gy) using a 137 Cs source. Six and 12 h after irradiation, total RNA was purified using RNeasy Mini kit (Qiagen, Hilden, Germany) and reverse transcribed using SuperScriptIII First Strand (Invitrogen) plus Oligo dT primers (Invitrogen). Realtime PCR was performed with an Rotor-Gene 6000 (Corbett Life Sciences, Sydney, Australia), with Sybr Green PCR Master Mix (Applied Biosystems, Foster City, CO, USA). The PCR conditions were as follows: 10 min at 95 1C, 55 cycles of 30 s at 95 1C, 30 s at 60 1C and 40 s at 72 1C. The average C t value was determined from triplicate reactions and levels of p21 mRNA relative to glyceraldehyde 3-phosphate dehydrogenase were calculated as described (Wendt et al., 2006) . The primers for the PCR are listed in Table 2 in Supplementary data.
Antibodies and protein analysis
Primary antibodies used in this study included E1B-55K monoclonal antibodies 2A6 (Sarnow et al., 1982) and 7C11 (Kindsmuller et al., 2007) ; a-E1A monoclonal antibodies M73 (Harlow et al., 1985) , a-E4orf6 1807 (Boivin et al., 1999) , a-p53 DO-1 and FL393 (Santa Cruz, Heidelberg, Germany); a-b-actin AC-15 (Sigma-Aldrich, Munich, Germany); a-Mre11 pNB 100-142 (Novus Biologicals, Littleton, CO, USA); a-vimentin V6630 (Sigma-Aldrich); a-g-tubulin AB11320 (Abcam, Cambridge, UK), a-Rad50 pNB 100-154 (Novus Biologicals Inc.); a-phospho-g-H2AX 05-636 (Upstate/Millipore, Schwalbach, Germany) and a-EGFP Sc-8334 (Santa Cruz). Horseradish peroxidase-conjugated secondary antibodies (Amersham Biosciences, Piscataway, NJ, USA) were used for detection of proteins by immunoblotting. Affinity purified fluorescein isothiocyanate-conjugated donkey anti-mouse, anti-rabbit and anti-rat IgG, and Texas Redconjugated donkey anti-rat, anti-mouse IgG (Dianova, Hamburg, Germany) were used as fluorescent secondary antibodies.
Protein analysis was performed as described (Endter et al., 2005) . For immunoprecipitation protein A-Sepharose (30 mg ml À1 ) was incubated with 1 ml hybridoma supernatant 2A6 for 2 h at room temperature. The antibodies bound to protein A-Sepharose were added to the protein A-Sepharose precleared extracts and centrifuged overnight at 4 1C. The immune complexes were separated by SDS-polyacrylamide gel electrophoresis and analysed by immunoblotting. The bands were visualized by enhanced chemiluminescence on X-ray films (Pierce, Rockford, IL, USA).
Indirect immunofluorescence
For indirect immunofluorescence, cells were grown on glass coverslips, fixed and treated with the appropriated primary and secondary antibodies as described (Endter et al., 2001) . Coverslips were washed three times in phosphate buffered saline Tween-20, mounted in Glow medium (Energene, Regensburg, Germany) and digital images were acquired with a DMRB fluorescence microscope (Leica and Diagnostic Instruments, Wetzlar, Germany) with a charge-coupled device camera (Diagnostic Instruments).
